X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (154) 154
dermatology (122) 122
female (92) 92
male (92) 92
middle aged (79) 79
adult (72) 72
index medicus (72) 72
aged (65) 65
life sciences (33) 33
aged, 80 and over (30) 30
therapy (27) 27
treatment outcome (27) 27
cancer (25) 25
melanoma (23) 23
oncology (23) 23
retrospective studies (23) 23
skin neoplasms - pathology (22) 22
hematology (21) 21
prognosis (21) 21
child (19) 19
skin (19) 19
adolescent (18) 18
chemistry (17) 17
diagnosis, differential (17) 17
young adult (15) 15
diagnosis (14) 14
metallurgy (14) 14
rituximab (13) 13
skin neoplasms - drug therapy (13) 13
follow-up studies (12) 12
prospective studies (12) 12
[sdv.can]life sciences [q-bio]/cancer (11) 11
analysis (11) 11
apparatus therefor (11) 11
care and treatment (11) 11
dermatology & venereal diseases (11) 11
electrolytic or electrophoretic processes (11) 11
electrolytic or electrophoretic processes for the productionof compounds or non-metals (11) 11
lymphoma (11) 11
medicine, general & internal (11) 11
animals (10) 10
chemotherapy (10) 10
combined modality therapy (10) 10
disease (10) 10
malignant-melanoma (10) 10
medicine, research & experimental (10) 10
mice (10) 10
pemphigus (10) 10
skin diseases (10) 10
skin neoplasms - genetics (10) 10
t-cell lymphoma (10) 10
time factors (10) 10
antineoplastic agents - therapeutic use (9) 9
biopsy (9) 9
child, preschool (9) 9
france (9) 9
immunology (9) 9
mycosis fungoides (9) 9
neoplasm staging (9) 9
photopheresis (9) 9
skin neoplasms - diagnosis (9) 9
vulgaris (9) 9
age factors (8) 8
allergy (8) 8
classification (8) 8
follow-up (8) 8
immunotherapy (8) 8
medical research (8) 8
melanoma - genetics (8) 8
remission induction (8) 8
skin - pathology (8) 8
skin neoplasms - mortality (8) 8
survival analysis (8) 8
transplantation (8) 8
[ sdv.can ] life sciences [q-bio]/cancer (7) 7
abridged index medicus (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
autoantibodies (7) 7
cell biology (7) 7
children (7) 7
chronic disease (7) 7
lymphomas (7) 7
melanoma - secondary (7) 7
pathology (7) 7
pemphigus - drug therapy (7) 7
recommendations (7) 7
remission (7) 7
risk factors (7) 7
survival (7) 7
survival rate (7) 7
[sdv]life sciences [q-bio] (6) 6
adrenal cortex hormones - therapeutic use (6) 6
antibodies, monoclonal, murine-derived (6) 6
biochemistry (6) 6
cutaneous melanoma (6) 6
cystemustine (6) 6
disease-free survival (6) 6
drug therapy (6) 6
drug therapy, combination (6) 6
expression (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10083, pp. 2031 - 2040
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10094, pp. 555 - 566
Journal Article
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 12/2008, Volume 128, Issue 12, pp. 2859 - 2869
Journal Article
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 07/2016, Volume 175, Issue 1, pp. 142 - 149
Summary Background Two pemphigus severity scores, Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI), have been... 
CRITERIA | VULGARIS | SEVERITY | DERMATOLOGY | Pemphigus - diagnosis | Severity of Illness Index | Diagnosis, Differential | Prospective Studies | Skin Diseases, Vesiculobullous - diagnosis | Humans | Middle Aged | Male | Reference Values | Aged, 80 and over | Adult | Female | Aged | Pemphigus | Skin | Pemphigus vulgaris | Skin diseases | Dermatology | Pemphigus foliaceus | Life Sciences | Human health and pathology
Journal Article
The British journal of dermatology, ISSN 0007-0963, 09/2019
Corticosteroids (CS) with or without adjuvant immunosuppressant agents are standard treatment for pemphigus vulgaris (PV). The efficacy of adjuvant therapies... 
Journal Article
JOURNAL OF INVESTIGATIVE DERMATOLOGY, ISSN 0022-202X, 01/2019, Volume 139, Issue 1, pp. 31 - 37
The Pemphigus Disease Area Index (PDAI) and Autoimmune Bullous Skin Disorder Intensity-Score (ABSIS) scores have been proposed to provide an objective measure... 
AUTOANTIBODIES | DISORDER INTENSITY SCORE | VULGARIS | DISEASE AREA INDEX | OUTCOME INSTRUMENTS | DERMATOLOGY
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 01/2010, Volume 162, Issue 1, pp. 74 - 79
Journal Article
ANTI-CANCER DRUGS, ISSN 0959-4973, 10/2005, Volume 16, Issue 9, pp. 1003 - 1007
Nitrosoureas possess some anti-tumor activity as a single agent in metastatic melanoma (MM). In a phase 11 trial, we evaluated the anti-tumor effects of... 
second-line treatment | DACARBAZINE | COMBINATION | CANCER | cystemustine | TUMOR XENOGRAFTS | THERAPY | CISPLATIN | ONCOLOGY | metastatic melanoma | PHARMACOLOGY & PHARMACY | AGENTS | nitrosourea | phase II trial
Journal Article